Physician profile
Shayne Erman
NPI 1740637685
$1,428.12
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $80.76 · 2021: $225 · 2023: $133 · 2024: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $369.96 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $283.17 | 2019-2024 | Portfolio, Jaws |
| Stryker Corporation | $177.08 | 2019-2020 | |
| Bioventus LLC | $121.53 | 2019 | |
| Organogenesis INC. | $119.23 | 2019-2021 | |
| Orthofix Medical, INC. | $77.20 | 2019-2021 | |
| Horizon Therapeutics Plc | $76.22 | 2019 | |
| Rock Medical Orthopedics, INC. | $68.97 | 2021 | |
| Smith+Nephew, INC. | $42.17 | 2021 | |
| Coastal Medical Technologies LLC | $28.69 | 2024 | |
| Celularity INC. | $28.00 | 2019 | |
| Medtronic USA, INC. | $13.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.72 | 2019 | |
| Amniox Medical, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shayne Erman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.